Sales increased by 72 per cent compared with the first three months of the previous year to €288 million (Q1 2019: €168 million). The growth is mainly the result of the strong project business in the U.S. and the ongoing positive trade business in Europe. From January to March 2020, EBITDA amounted to €12 million, considerably higher than the comparative figure for the previous year (EBITDA margin: 4.3%; Q1 2019: €1 million, 0.4%). Order intake developed positively in all market segments in the first quarter.
Net income broke even in the first quarter of 2020 (Q1 2019: –€11 million). Earnings per share thus amounted to –€0.01 (Q1 2019: –€0.30). With net cash of €243 million (December 31, 2019: €303 million) and an equity ratio of 40.3% (December 31, 2019: 37.6%), SMA continues to have a solid balance-sheet structure.
Maintained production capacity through the coronavirus crisis
“SMA made a good start to 2020,” said SMA CEO Jürgen Reinert. “We increased sales and earnings considerably in the first quarter and generated positive EBIT of €1.6 million. Order intake also continued to develop very well at €330 million in the first three months of the year. Through active management and process adjustments, we have maintained our supply chain and our production capacity in the coronavirus crisis and suffered only minor supply shortages. The sales and product-related order backlog of the first quarter already cover over 60 per cent of the Managing Board’s sales projections for the 2020 fiscal year. On this basis, we continue to assume that we will meet our sales and earnings targets and increase our market shares in key target markets.”
Despite the current coronavirus crisis, the SMA Managing Board is confirming its projections on sales and earnings for the 2020 fiscal year published on February 7, 2020. It predicts a sales increase to between €1 billion and €1.1 billion. SMA is well positioned to gain market shares even in the current circumstances. In addition, the Managing Board is implementing further cost reduction measures. In this context, the SMA Managing Board is still expecting an increase in EBITDA of between €50 million and €80 million. (mfo)
